Future Market Insights (FMI) forecasts impressive prospects for the incontinence skincare products market. In one of its recent reports, FMI has forecast the market to expand at a CAGR of 6% between 2020 and 2030. The rising prevalence of urinary incontinence is resulting in higher demand for associated skin care products.
- To Get a Sample Copy of the Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11929
Urinary incontinence can cause severe skin infection. Studies suggest women are at higher risk of urinary incontinence which may occur during pregnancy or childbirth. Menopause and pelvic surgeries are also identified as underlying causes behind urinary incontinence in women. Other surveys suggest, prevalence of incontinence is higher among women aged 40 years and older.
According to FMI, offerings in the incontinence skincare products market are expected to surge driven by the increasing demand across the world. The market is projected to reach US$ 4 Bn by the end of 2030, bolstered by expansion strategies adopted by the leading players.
In its report FMI offers insights into the key factors affecting the trajectory of the incontinence skincare products market. It also highlights the hidden opportunities within the market. It conducts qualitative analysis on the prevailing trends to offer refined growth projections. The report is intended to help the market players uncover lucrative prospects within the market.
Some of the key takeaways from the report are:
- Inclusive social media campaigns and expansion of ecommerce channels are fuelling growth
- Market players are leveraging their brand equity besides expanding their portfolio to gain competitive edge
- The demand in the gels and oils category will remain high cementing their position as the leading product category
- Unprecedented COVID-19 outbreak will spur sales as consumers are likelier to stockpile on essential medical supplies especially when entering into an extended period of isolation
Request Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-11929
COVID-19 Outbreak to Spur Sales of Incontinence Skincare ProductsThe market is witnessing higher sales due to the unprecedented COVID-19 outbreak. Since majority of consumers are aged or seniors, there is higher demand for incontinence skincare products as they stockpile on essential medical supplies to sustain during extended periods of self-isolation.
The market is expected to showcase a strong performance driven by the rising aging population and openness to incontinence skincare solutions brought about by rising awareness.
Who is winning?Some of the companies profiled by FMI are Coloplast A/S, Svenska Cellulosa AB, GAMA Healthcare Ltd., 3M Company, Vernacare Ltd., Attends Healthcare Group Ltd., ConvaTec Group PLC, CliniMed, Ltd., Kimberly-Clark Corp., B Braun Melsungen AG, Hollister Incorporated, McKesson Corporation, Smith & Nephew Plc, Ontex Group N.V, Medline Industries Inc., among others.
Several incontinence skincare products companies are launching campaigns to spread awareness and break the existing stigma restricting users to invest in better hygiene. One such company is Svenska Cellulosa AB that is frequently launching campaigns to promote incontinence awareness among consumers.
Key SegmentsProduct Type
- Creams
- Lotions
- Washes/ Cleansers
- Gels/Oils
- Wipes
End User
- Men
- Women
Price Range
- Economy Range
- Mid-Range
- Premium
Sales Channel
- Wholesalers and Distributors
- Online Retailers
- Hypermarkets and Supermarkets
- Specialty Stores
- Pharmacies/ Drug Stores
- Convenience Stores
- Other Sales Channel
Region
- North America
- Latin America
- Europe
- East Asia
- South Asia & Pacific
- MEA
Buy Now @ https://www.futuremarketinsights.com/checkout/11929